Narmafotinib

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameNarmafotinib
Drug Alias NameAMP-945AMP945CTX-0294945
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFocal adhesion kinase inhibitors
TargetsFocal adhesion kinase
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCancer Therapeutics CRC Pty LtdYM BioSciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmplia Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank